Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00265746Phase 4Withdrawn
Phase 4, randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medical University of Lodz. Primary endpoint: Incidence of type 2 diabetes mellitus. Planned start Nov 2005; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00265746.